Curaleaf Holdings (CURLF) Assets Average (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Assets Average of $3.0 billion for Q4 2024, down 4.72% year-over-year from $3.2 billion in Q1 2024, and down 2.16% quarter-over-quarter from $3.1 billion in Q3 2024.
Curaleaf Holdings (CURLF) Assets Average (2020 - 2024) Analysis & Trends
Curaleaf Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $3.0 billion for Q4 2024.
- In Q4 2024, Assets Average fell 4.72% year-over-year to $3.0 billion; the TTM figure through Dec 2024 stood at $3.0 billion (down 4.72% YoY), while the FY2025 annual figure was $2.9 billion, down 4.16% from the prior year.
- Assets Average for Q4 2024 stood at $3.0 billion, down from $3.1 billion in the prior quarter.
- The five-year high for Assets Average was $3.3 billion in Q3 2023, with the low at $737.0 million in Q3 2022.
- The 5-year median for Assets Average is $2.5 billion (2021), against an average of $2.4 billion.
- The sharpest annual moves came in 2022 and 2023: Assets Average plunged 76.71% in 2022, then jumped 342.99% in 2023.
- Curaleaf Holdings' Assets Average stood at $2.4 billion in 2020, then retreated by 17.2% to $2.0 billion in 2021, then plunged by 62.32% to $737.0 million in 2022, then soared by 328.96% to $3.2 billion in 2023, then decreased by 4.72% to $3.0 billion in 2024.
- Business Quant data shows CURLF's Assets Average at $3.0 billion in Q4 2024, $3.1 billion in Q3 2024, and $3.2 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.01 Bn |
| Sep 30, 2024 | 3.08 Bn |
| Dec 31, 2023 | 3.16 Bn |
| Sep 30, 2023 | 3.26 Bn |
| Dec 31, 2022 | 737.03 Mn |
| Sep 30, 2022 | 737.03 Mn |
| Jun 30, 2022 | 2.14 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 1.96 Bn |
| Sep 30, 2021 | 3.16 Bn |
| Jun 30, 2021 | 2.92 Bn |
| Mar 31, 2021 | 2.52 Bn |
| Dec 31, 2020 | 2.36 Bn |